Modalis Therapeutics Corp
TSE:4883

Watchlist Manager
Modalis Therapeutics Corp Logo
Modalis Therapeutics Corp
TSE:4883
Watchlist
Price: 146 JPY -1.35% Market Closed
Market Cap: 9.4B JPY
Have any thoughts about
Modalis Therapeutics Corp?
Write Note

Modalis Therapeutics Corp
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Modalis Therapeutics Corp
Capital Expenditures Peer Comparison

Comparables:
2160
4587
4974
2929
C
4894

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Modalis Therapeutics Corp
TSE:4883
Capital Expenditures
-ÂĄ39.7m
CAGR 3-Years
64%
CAGR 5-Years
-136%
CAGR 10-Years
N/A
GNI Group Ltd
TSE:2160
Capital Expenditures
-ÂĄ1.8B
CAGR 3-Years
-71%
CAGR 5-Years
-20%
CAGR 10-Years
-24%
PeptiDream Inc
TSE:4587
Capital Expenditures
-ÂĄ1.8B
CAGR 3-Years
-53%
CAGR 5-Years
-55%
CAGR 10-Years
-38%
Takara Bio Inc
TSE:4974
Capital Expenditures
-ÂĄ12.2B
CAGR 3-Years
-6%
CAGR 5-Years
-17%
CAGR 10-Years
-10%
Pharma Foods International Co Ltd
TSE:2929
Capital Expenditures
-ÂĄ973m
CAGR 3-Years
-78%
CAGR 5-Years
-28%
CAGR 10-Years
-55%
C
Cuorips Inc
TSE:4894
Capital Expenditures
-ÂĄ35.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Modalis Therapeutics Corp's Capital Expenditures?
Capital Expenditures
-39.7m JPY

Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Capital Expenditures amounts to -39.7m JPY.

What is Modalis Therapeutics Corp's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-136%

Over the last year, the Capital Expenditures growth was 80%. The average annual Capital Expenditures growth rates for Modalis Therapeutics Corp have been 64% over the past three years , -136% over the past five years .

Back to Top